Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 230,909 | 292,028 | 347,005 | 391,883 | 370,492 |
| Receivables | 5,564 | 3,974 | 32,064 | 2,764 | 3,367 |
| TOTAL | $241,446 | $305,979 | $386,590 | $403,333 | $378,961 |
| Non-Current Assets | |||||
| PPE Net | 6,736 | 9,531 | 12,427 | 12,415 | 5,643 |
| Investments And Advances | 0 | 0 | 0 | 0 | 515 |
| Other Non-Current Assets | 22,966 | 28,559 | 30,385 | 34,639 | 7,695 |
| TOTAL | $29,702 | $38,090 | $42,812 | $47,054 | $13,853 |
| Total Assets | $271,148 | $344,069 | $429,402 | $450,387 | $392,814 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 60,655 | 22,474 |
| Accounts payable and accrued liabilities | 4,235 | 7,194 | 5,279 | 7,449 | 10,058 |
| Accrued Expenses | 23,898 | 38,781 | 31,881 | 30,232 | 23,523 |
| TOTAL | $36,379 | $65,489 | $81,989 | $126,984 | $99,537 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 40,633 |
| Deferred Revenues | 8,246 | 19,514 | 44,829 | 28,648 | 43,482 |
| Other Non-Current Liabilities | 20,784 | 24,998 | 26,404 | 33,020 | 4,502 |
| TOTAL | $20,784 | $37,602 | $68,900 | $53,091 | $65,066 |
| Total Liabilities | $57,163 | $103,091 | $150,889 | $180,075 | $164,603 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 27,120 | 26,915 | 26,555 | N/A |
| Common Shares | 28 | 27 | 27 | 27 | 26 |
| Retained earnings | -514,590 | -448,807 | -367,866 | -338,141 | -347,490 |
| TOTAL | $213,985 | $240,978 | $278,513 | $270,312 | $228,211 |
| Total Liabilities And Equity | $271,148 | $344,069 | $429,402 | $450,387 | $392,814 |